Supreme Court Deals Blow To Big Pharma Over Little-Known ACA Provision

The case hinged on a little-known aspect of the Affordable Care Act that would expedite the release of generic drugs, a provision contested by major pharmaceuticals firms.

The Amgen headquarters in Thousand Oaks, Calif. (AP/Mark J. Terrill)

The Supreme Court dealt a blow to big pharma on Monday, ruling that companies making generic “biosimilars” to brand-name drugs don’t have to wait an extra six months after gaining federal approval before selling their drugs. The ruling, written by Justice Clarence Thomas for the unanimous court, is expected to speed up how quickly generic drugs

Be Sociable, Share!

Big Pharma’s Pollution Is Creating Deadly Superbugs, While The World Looks The Other Way

Environmental standards do not feature in international regulations governing drug production.

A microbiologist works with tubes of bacteria samples in an antimicrobial resistance and characterization lab within the Infectious Disease Laboratory at the Centers for Disease Control and Prevention in Atlanta. (AP/David Goldman)

Industrial pollution from Indian pharmaceutical companies making medicines for nearly all the world’s major drug companies is fuelling the creation of deadly superbugs, suggests new research. Global health authorities have no regulations in place to stop this happening. A major study published today in the prestigious scientific journal

Be Sociable, Share!

Secretive US Trade Deal Could Endanger Global Health Gains

Much of the concern focuses on a host of provisions that would impact the ability of poor communities to get cheap generic medicines.

WASHINGTON --- As a major free trade agreement nears the end of negotiations, the United States appears to be doubling down and even strengthening its demands for restrictive new provisions that public health advocates warn would significantly curtail access to affordable medicines and health care in developing countries. Internal documents

Be Sociable, Share!

Obamacare Fails To Address High Drug Prices

The ACA’s implementation will see few of the prescription drug reforms Barack Obama once promised.

With the implementation of the Affordable Care Act, the price of prescription drugs, including generic ones, may not be as affordable as some Americans had anticipated or hoped. Though originally touted as a piece of legislation that would grant U.S. consumers access to safe and affordable drugs, heavy lobbying by Big Pharma -- specifically the

Be Sociable, Share!

Ill-Gotten Gains: Big Pharma’s Sick Hold On Doctors And The Health Care Economy

Patients’ needs compete with the dancing dollar signs in their physicians’ heads.

Pharmaceutical companies’ grip on the practice of medicine and healthcare is near absolute. From its influence over medical students to the bribing of their generic drug-making competition, Big Pharma has shown that making more money is preferable to making more people well.   Educate to disseminate A study published in the Journal of

Be Sociable, Share!

Supreme Court: Big Pharma’s Paying To Delay Generic Drugs Can Be Challenged In Courts

Drug companies had hoped the court to would immunize their agreements, which keep cheaper forms of medicine off the market.

Prescription drugs line a cabinet in this March 25, 2011 photo. (Photo by Eric Hunsaker via Flikr)

WASHINGTON — Deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can sometimes be illegal and therefore can be challenged in court, the Supreme Court said Monday. The justices voted 5-3 to allow the government to inspect and challenge what it

Be Sociable, Share!